Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00812ApprovedVet approvedWithdrawnSmall molecule
Phenylbutazone is an NSAID used to treat backache and ankylosing spondylitis. A drug that has anti-inflammatory, antipyretic, and analgesic activities.
- Mechanism
- Curator reviewed
Phenylbutazone binds to and inactivates prostaglandin H synthase and prostacyclin synthase through peroxide (H2O2) mediated deactivation. The reduced production of prostaglandin leads to reduced inflammation of the surrounding tissues.
- Primary indication
- For the treatment of backache and ankylosing spondylitisCurator reviewed · 3 structured indications
- Formula / weight
- C19H20N2O2 · 308.3743 g/mol (avg)
- First approval
- Canada, 1974
- Also known as
- Phenbutazone
- Code names
- G-13871 · NSC-25134 · USAF Ge-15
Resolves to
Clinical / RWD
Structure
InChIKey
VYMDGNCVAMGZFE-UHFFFAOYSA-NSMILESCCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1Transporters
What you can answer from here — as of September 23, 2026
4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Phenylbutazone, and which of those have an active Phase 3 trial?